PANGLOBULIN Side Effects

5922636-9 | Basal Ganglia Haemorrhage, Blood Pressure Inadequately Controlled, Cerebral Vasoconstriction, Coagulopathy, Dyspnoea, Haemorrhagic Stroke, Hypertension, Ischaemic Stroke
on Sep 15, 2008 Female patient from UNITED STATES , 66 years of age, was diagnosed with guillain-barre syndrome (What is guillain-barre syndrome?) and was treated with Panglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: basal ganglia haemorrhage, blood pressure inadequately controlled, cerebral vasoconstriction, coagulopathy, dyspnoea, haemorrhagic stroke, hypertension, ischaemic stroke. Panglobulin dosage: Iv.

5179139-1 | Dialysis, Infusion Related Reaction, Lung Infiltration, Oedema Peripheral, Pneumonia, Po2 Decreased, Renal Failure Acute
Patient was taking Panglobulin (View Usage). Patient had the following side effects: dialysis (What is dialysis?), infusion related reaction, lung infiltration, oedema peripheral, pneumonia (What is pneumonia?), po2 decreased, renal failure acute on Nov 21, 2006 from UNITED STATES Additional patient health information: Male patient , 55 years of age, weighting 210.0 lb, was diagnosed with polyneuropathy and. Panglobulin dosage: 48 G Qd Iv. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), ALTACE (View Altace Review and Altace Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ). Patient was hospitalized.

5179012-9 | Dyspnoea, Renal Failure Acute
Adverse event was reported on Dec 14, 2006 by a Male patient taking Panglobulin (View Usage) (Dosage: 96 Gm) was diagnosed with idiopathic thrombocytopenic purpura and. Location: UNITED STATES , 73 years of age, After Panglobulin was administered, patient had the following side effects: dyspnoea, renal failure acute. Patient was hospitalized.

5140569-5 | Dialysis, Interstitial Lung Disease, Oedema Peripheral, Pneumonia, Renal Failure Acute
on Oct 13, 2006 Male patient from UNITED STATES , 55 years of age, weighting 210.0 lb, was diagnosed with polyneuropathy and was treated with Panglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: dialysis (What is dialysis?), interstitial lung disease, oedema peripheral, pneumonia (What is pneumonia?), renal failure acute. Panglobulin dosage: 48 G Qd Iv. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), ALTACE (View Altace Review and Altace Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ). Patient was hospitalized.


5140569-5 | Dialysis, Interstitial Lung Disease, Oedema Peripheral, Pneumonia, Renal Failure Acute
on Oct 13, 2006 Male patient from UNITED STATES , 55 years of age, weighting 210.0 lb, was diagnosed with polyneuropathy and was treated with Panglobulin (View Usage). Patient had the following side effects: dialysis (What is dialysis?), interstitial lung disease, oedema peripheral, pneumonia (What is pneumonia?), renal failure acute. Panglobulin dosage: 48 G Qd Iv. Patient was hospitalized.

5132860-3 | Blood Pressure Immeasurable, Body Temperature Increased, Capillary Nail Refill Test, Crying, Cyanosis, Infusion Related Reaction, Tremor, Vascular Test Abnormal
Patient was taking Panglobulin (View Usage). After Panglobulin was administered, patient had the following side effects: blood pressure immeasurable, body temperature increased, capillary nail refill test, crying, cyanosis, infusion related reaction, tremor, vascular test abnormal on Oct 19, 2006 from UNITED STATES Additional patient health information: Female patient , weighting 17.77 lb, was diagnosed with kawasaki's disease and. Panglobulin dosage: 16.5 Gm X 1. Patient was hospitalized.

5129095-7 | Dialysis, Interstitial Lung Disease, Pneumonia, Renal Failure Acute
Adverse event was reported on Oct 16, 2006 by a Male patient taking Panglobulin (View Usage) (Dosage: 48 Gm/800ml Daily X 4 Days Iv) was diagnosed with polyneuropathy and. Location: UNITED STATES , 55 years of age, weighting 210.0 lb, Patient experienced the following unwanted or unexpected effects: dialysis (What is dialysis?), interstitial lung disease, pneumonia (What is pneumonia?), renal failure acute. Patient was hospitalized.

5075937-3 | Dyspnoea, Haemodialysis, Renal Failure Acute
on Aug 08, 2006 Male patient from UNITED STATES , 58 years of age, weighting 285.5 lb, was diagnosed with demyelinating polyneuropathy and was treated with Panglobulin (View Usage). Patient had the following side effects: dyspnoea, haemodialysis, renal failure acute. Panglobulin dosage: 0.4 G/kg/day. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), DOXAZOSIN (View Doxazosin Review and Doxazosin Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FLUVASTATIN XL (View Fluvastatin Xl Review and Fluvastatin Xl Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

4959119-9 | Back Pain, Burning Sensation, Chest Discomfort, Chills, Dizziness, Dysphonia, Dyspnoea, Ear Pain, Fatigue
on Mar 30, 2006 Female patient from UNITED STATES , 69 years of age, weighting 175.3 lb, was treated with Panglobulin (View Usage). After Panglobulin was administered, patient had the following side effects: back pain (What is back pain?), burning sensation, chest discomfort, chills, dizziness (What is dizziness?), dysphonia, dyspnoea, ear pain, fatigue. Panglobulin dosage: . During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), AVELOX (View Avelox Review and Avelox Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), THIOMERSOL (View Thiomersol Review and Thiomersol Label ).

4901926-2 | Arrhythmia, Electrocardiogram T Wave Inversion
Patient was taking Panglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), electrocardiogram t wave inversion on Feb 03, 2006 from UNITED STATES Additional patient health information: Male patient , 67 years of age, weighting 211.0 lb, was diagnosed with anaemia haemolytic autoimmune and. Panglobulin dosage: 38 Grams Daily Iv Drip. During the same period patient was treated with CARVIDELOL (View Carvidelol Review and Carvidelol Label ), DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ), K DUR 10 (View K-dur 10 Review and K-dur 10 Label ), CIPRO (View Cipro Review and Cipro Label ), DOCUASTE (View Docuaste Review and Docuaste Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), DEXAETHASONE (View Dexaethasone Review and Dexaethasone Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ).

4894460-X | Renal Failure Acute
Adverse event was reported on Jan 05, 2006 by a Male patient taking Panglobulin (View Usage) (Dosage: 1 G/kg B.w. Daily Iv) was diagnosed with aplasia pure red cell, erythema infectiosum and. Location: UNITED STATES , 14 years of age, Patient had the following side effects: renal failure acute. During the same period patient was treated with BASILIXIMAB (View Basiliximab Review and Basiliximab Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), EPOGEN (View Epogen Review and Epogen Label ), IRON (View Iron Review and Iron Label ), GANCICLOVIR (View Ganciclovir Review and Ganciclovir Label ).

4823855-5 | Anaphylactic Reaction, Asthma, Condition Aggravated
on Sep 20, 2005 Female patient from UNITED STATES , 47 years of age, weighting 168.0 lb, was diagnosed with immunoglobulins decreased and was treated with Panglobulin (View Usage). After Panglobulin was administered, patient had the following side effects: anaphylactic reaction, asthma (What is asthma?), condition aggravated. Panglobulin dosage: Iv. During the same period patient was treated with PULMICORT (View Pulmicort Review and Pulmicort Label ), DUONEB (View Duoneb Review and Duoneb Label ), PREVACID (View Prevacid Review and Prevacid Label ).

4742035-5 | Renal Failure Acute
on Jan 05, 2005 Male patient from UNITED STATES , 90 years of age, weighting 158.7 lb, was diagnosed with gammopathy, renal disorder and was treated with Panglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Panglobulin dosage: 1 G/kg B.w., I.v.. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CILOSTAZOL (View Cilostazol Review and Cilostazol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), METOLAZONE (View Metolazone Review and Metolazone Label ), TORSEMIDE (TORASEMIDE) (View Torsemide (torasemide) Review and Torsemide (torasemide) Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

4742034-3 | Anuria, Renal Failure Acute, Urine Abnormality, Urine Output Decreased
Patient was taking Panglobulin (View Usage). Patient had the following side effects: anuria, renal failure acute, urine abnormality, urine output decreased on Jan 05, 2005 from UNITED STATES Additional patient health information: Male patient , 44 years of age, weighting 194.0 lb, was diagnosed with panel-reactive antibody increased and. Panglobulin dosage: 1 G/kg B.w., O.a.d., I.v.. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL) (View Mycophenolate Mofetil (mycophenolate Mofetil) Review and Mycophenolate Mofetil (mycophenolate Mofetil) Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), THIAMINE (THIAMINE) (View Thiamine (thiamine) Review and Thiamine (thiamine) Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ).

4742033-1 | Anorexia, Blood Creatinine Increased, Fatigue, Renal Failure Acute, Urine Output Decreased
Adverse event was reported on Dec 13, 2004 by a Male patient taking Panglobulin (View Usage) (Dosage: 0.5 G/kg B.w., O.a.d., I.v.) was diagnosed with polyneuropathy and. Location: UNITED STATES , 76 years of age, After Panglobulin was administered, patient had the following side effects: anorexia, blood creatinine increased, fatigue, renal failure acute, urine output decreased. Patient was hospitalized.

4734062-9 | Renal Failure Acute, Renal Tubular Necrosis
on Aug 03, 2005 Female patient from UNITED STATES , 77 years of age, weighting 139.0 lb, was treated with Panglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute, renal tubular necrosis. Panglobulin dosage: 50 Grams Every 24 Hours Iv. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ).

4713466-4 | Areflexia, Autonomic Nervous System Imbalance, Brain Oedema, Cerebral Haemorrhage, Dysphagia, Dyspnoea, Hypertension, Ischaemic Stroke
on Jun 21, 2005 Female patient from UNITED STATES , 66 years of age, was diagnosed with guillain-barre syndrome (What is guillain-barre syndrome?) and was treated with Panglobulin (View Usage). Patient had the following side effects: areflexia, autonomic nervous system imbalance, brain oedema, cerebral haemorrhage, dysphagia, dyspnoea, hypertension, ischaemic stroke. Panglobulin dosage: O.a.d., I.v.. Patient was hospitalized.

4695732-4 | Cerebrovascular Accident
Patient was taking Panglobulin (View Usage). After Panglobulin was administered, patient had the following side effects: cerebrovascular accident on Jun 15, 2005 from Additional patient health information: Female patient , 66 years of age, was diagnosed with guillain-barre syndrome (What is guillain-barre syndrome?) and. Panglobulin dosage: 25 Grams Iv Qd. Patient was hospitalized.

4620673-8 | False Positive Laboratory Result
Adverse event was reported on Mar 09, 2005 by a Female patient taking Panglobulin (View Usage) (Dosage: Monthly) was diagnosed with immunodeficiency common variable and. Location: , 39 years of age, Patient experienced the following unwanted or unexpected effects: false positive laboratory result.

4595546-X | Haemodialysis, Renal Failure Acute
on Feb 28, 2005 Female patient from , 57 years of age, weighting 253.5 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with Panglobulin (View Usage). Patient had the following side effects: haemodialysis, renal failure acute. Panglobulin dosage: 115gm Iv Q24h X 2 Doses.

4569030-3 | Hepatitis C Virus
on Jan 14, 2005 Female patient from , 39 years of age, was diagnosed with immunodeficiency common variable and was treated with Panglobulin (View Usage). After Panglobulin was administered, patient had the following side effects: hepatitis c virus. Panglobulin dosage: Monthly.

4555595-4 | Blood Creatinine Increased
Patient was taking Panglobulin (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased on Jan 18, 2005 from Additional patient health information: Male patient , weighting 174.6 lb, was diagnosed with idiopathic thrombocytopenic purpura and. Panglobulin dosage: 78gm X3 Doses Intravenous. Patient was hospitalized.